PT721342E - Polipeptidos da familia do gene da semaforina - Google Patents
Polipeptidos da familia do gene da semaforinaInfo
- Publication number
- PT721342E PT721342E PT94928057T PT94928057T PT721342E PT 721342 E PT721342 E PT 721342E PT 94928057 T PT94928057 T PT 94928057T PT 94928057 T PT94928057 T PT 94928057T PT 721342 E PT721342 E PT 721342E
- Authority
- PT
- Portugal
- Prior art keywords
- semaphorin
- semaphorins
- nucleic acids
- cell growth
- methods
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 108050003978 Semaphorin Proteins 0.000 abstract 6
- 102000014105 Semaphorin Human genes 0.000 abstract 5
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 208000012902 Nervous system disease Diseases 0.000 abstract 2
- 208000025966 Neurological disease Diseases 0.000 abstract 2
- 230000002068 genetic effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 238000013507 mapping Methods 0.000 abstract 1
- 230000005709 nerve cell growth Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/60—New or modified breeds of invertebrates
- A01K67/61—Genetically modified invertebrates, e.g. transgenic or polyploid
- A01K67/65—Genetically modified arthropods
- A01K67/68—Genetically modified insects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/121,713 US5639856A (en) | 1993-09-13 | 1993-09-13 | Semaphorin gene family |
Publications (1)
Publication Number | Publication Date |
---|---|
PT721342E true PT721342E (pt) | 2002-09-30 |
Family
ID=22398364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94928057T PT721342E (pt) | 1993-09-13 | 1994-09-13 | Polipeptidos da familia do gene da semaforina |
Country Status (11)
Country | Link |
---|---|
US (8) | US5639856A (pt) |
EP (1) | EP0721342B1 (pt) |
JP (1) | JP3544378B2 (pt) |
AT (1) | ATE214286T1 (pt) |
AU (1) | AU683494B2 (pt) |
CA (1) | CA2171638C (pt) |
DE (1) | DE69430130T2 (pt) |
DK (1) | DK0721342T3 (pt) |
ES (1) | ES2173922T3 (pt) |
PT (1) | PT721342E (pt) |
WO (1) | WO1995007706A1 (pt) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639856A (en) * | 1993-09-13 | 1997-06-17 | The Regents Of The University Of California | Semaphorin gene family |
US5654173A (en) * | 1996-08-23 | 1997-08-05 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
DE69637846D1 (de) | 1995-12-06 | 2009-04-09 | Dainippon Sumitomo Pharma Co | Neues semaphorin z und dafür kodierendes gen |
DE69738302T2 (de) * | 1996-09-11 | 2008-09-04 | Dainippon Sumitomo Pharma Co., Ltd. | Neues semaphorin-gen: semaphorin y |
WO1998013493A2 (en) * | 1996-09-24 | 1998-04-02 | Lxr Biotechnology, Inc. | A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
US20070299005A1 (en) * | 1996-09-24 | 2007-12-27 | Tanox, Inc. | Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
US6902730B1 (en) | 1996-10-09 | 2005-06-07 | Sumitomo Pharmaceuticals Company, Limited | Semaphorin gene: Semaphorin W |
WO1998022504A1 (fr) * | 1996-11-15 | 1998-05-28 | Sumitomo Pharmaceuticals Company, Limited | Nouveaux genes de semaphorine (i) |
EP0892047A3 (de) * | 1997-07-09 | 2000-03-08 | Hoechst Marion Roussel Deutschland GmbH | Humanes und murines Semaphorin L |
US6428965B1 (en) | 1997-07-17 | 2002-08-06 | The Johns Hopkins University | Screening assays for the interaction of semaphorins and neuropilins |
US20030027262A1 (en) * | 1997-09-18 | 2003-02-06 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7214497B2 (en) | 1997-10-28 | 2007-05-08 | Immunex Corporation | Viral encoded semaphorin protein receptor DNA and polypeptides |
US6130068A (en) * | 1998-10-26 | 2000-10-10 | Immunex Corporation | Viral encoded semaphorin protein receptor DNA and polypeptides |
US6562949B1 (en) | 1997-10-28 | 2003-05-13 | Immunex Corporation | Antibodies to viral encoded semaphorin protein receptor polypeptides |
EP1027436A1 (en) * | 1997-10-28 | 2000-08-16 | Immunex Corporation | Viral encoded semaphorin protein receptor dna and polypeptides |
US6635421B1 (en) * | 1997-12-09 | 2003-10-21 | Children's Medical Center Corporation | Neuropilins and use thereof in methods for diagnosis and prognosis of cancer |
WO1999032511A1 (fr) | 1997-12-22 | 1999-07-01 | Ono Pharmaceutical Co., Ltd. | Peptides, procede de dosage du pepsinogene ii humain ou de la pepsine ii humaine et necessaire de dosage |
JPH11187882A (ja) * | 1997-12-26 | 1999-07-13 | Ono Pharmaceut Co Ltd | 新規なポリペプチド、その製造方法、そのポリペプチドをコードするcDNA、そのcDNAからなるベクター、そのベクターで形質転換された宿主細胞、そのポリペプチドの抗体、およびそのペプチドまたは抗体を含有する薬学的組成物 |
WO1999038885A2 (en) * | 1998-01-30 | 1999-08-05 | Smithkline Beecham Plc | Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same |
EP0933425A1 (en) * | 1998-01-30 | 1999-08-04 | Smithkline Beecham Plc | Semaphorin family polypeptides and polynucleotides |
US20030166132A1 (en) * | 1998-08-26 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1135488A1 (en) * | 1998-11-26 | 2001-09-26 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Human semaphorin 6a-1 (sema6a-1), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
US20020049312A1 (en) * | 2000-05-23 | 2002-04-25 | Turner C. Alexander | Noel human thrombospondin-like proteins and polynucleotides encoding the same |
EP1210368A2 (en) * | 1999-09-08 | 2002-06-05 | Immunex Corporation | Use of semaphorin for modulation of cellular efflux |
US20080213878A1 (en) * | 1999-10-19 | 2008-09-04 | Gregory Donoho | Novel human membrane proteins and polynucleotides encoding the same |
WO2001032707A1 (en) * | 1999-11-02 | 2001-05-10 | Zymogenetics, Inc. | Human semaphorin |
AU4303101A (en) * | 1999-11-08 | 2001-06-04 | General Hospital Corporation, The | Novel semaphorin domains |
EP1268538A2 (en) * | 2000-03-20 | 2003-01-02 | Lexicon Genetics Incorporated | Human secreted proteins and polynucleotides encoding the same |
WO2001088133A2 (en) * | 2000-05-18 | 2001-11-22 | Lexicon Genetics Incorporated | Human semaphorin homologs and polynucleotides encoding the same |
WO2002009756A1 (fr) * | 2000-07-28 | 2002-02-07 | Sumitomo Pharmaceuticals Company, Limited | Promoteurs de la regeneration des nerfs contenant un inhibiteur de semaphorine en tant qu'ingredient actif |
CA2493718A1 (en) * | 2001-07-20 | 2003-01-30 | Paul F. Good | Methods for diagnosing and treating alzheimer's disease and parkinson's disease |
WO2003035100A1 (en) * | 2001-09-26 | 2003-05-01 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Neuropilin as a novel therapeutic target for modulation of immune reponses |
US7781413B2 (en) * | 2001-10-31 | 2010-08-24 | Board Of Regents, The University Of Texas System | SEMA3B inhibits tumor growth and induces apoptosis in cancer cells |
EP1572907A2 (en) * | 2002-02-04 | 2005-09-14 | The Johns Hopkins University | Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same |
EP1442749A1 (en) | 2003-01-31 | 2004-08-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system |
FR2876913A1 (fr) * | 2004-10-22 | 2006-04-28 | Centre Nat Rech Scient | Modulation de la transmission synaptique par les semaphorines et ses applications |
WO2008100995A1 (en) | 2007-02-14 | 2008-08-21 | Vaccinex, Inc. | Humanized anti-cd100 antibodies |
US8496938B2 (en) | 2009-05-08 | 2013-07-30 | Vaccinex, Inc. | Anti-CD100 neutralizing neutralizing antibodies and methods of using the same |
EA029023B1 (ru) | 2011-10-11 | 2018-01-31 | Вэксинекс, Инк. | Применение молекул, связывающих семафорин-4d, для модуляции проницаемости гематоэнцефалического барьера |
US9090709B2 (en) | 2012-03-28 | 2015-07-28 | Vaccinex, Inc. | Anti-SEMA4D antibodies and epitopes |
US10494440B2 (en) | 2012-05-11 | 2019-12-03 | Vaccinex, Inc. | Use of semaphorin-4D binding molecules to promote neurogenesis following stroke |
US9975933B2 (en) * | 2013-05-23 | 2018-05-22 | Ajou University Industry-Academic Cooperation Foundation | Tumor tissue-penetrating peptide specific to neuropilin and fusion protein having same peptide fused therein |
US9828435B2 (en) | 2013-06-25 | 2017-11-28 | Vaccinex, Inc. | Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency |
NZ630881A (en) | 2013-10-10 | 2016-03-31 | Vaccinex Inc | Use of semaphorin-4d binding molecules for treatment of atherosclerosis |
NZ630892A (en) | 2013-10-21 | 2016-03-31 | Vaccinex Inc | Use of semaphorin-4d binding molecules for treating neurodegenerative disorders |
CN107810192A (zh) * | 2015-02-23 | 2018-03-16 | 海鸥治疗简易股份公司 | 非天然的脑信号蛋白3及其医药用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE229543T1 (de) * | 1991-06-24 | 2002-12-15 | Chiron Corp | Polypeptide des hepatitis c-virus (hiv) |
US5639856A (en) * | 1993-09-13 | 1997-06-17 | The Regents Of The University Of California | Semaphorin gene family |
US5416197A (en) * | 1993-10-15 | 1995-05-16 | Trustees Of The University Of Pennsylvania | Antibodies which bind human collapsin |
US5807806A (en) * | 1997-06-12 | 1998-09-15 | Nippon Soda Co., Ltd. | Benzoylpyrazole derivatives having specific substituents and herbicide |
-
1993
- 1993-09-13 US US08/121,713 patent/US5639856A/en not_active Expired - Lifetime
-
1994
- 1994-09-13 WO PCT/US1994/010151 patent/WO1995007706A1/en active IP Right Grant
- 1994-09-13 ES ES94928057T patent/ES2173922T3/es not_active Expired - Lifetime
- 1994-09-13 JP JP50926195A patent/JP3544378B2/ja not_active Expired - Fee Related
- 1994-09-13 DK DK94928057T patent/DK0721342T3/da active
- 1994-09-13 AU AU77240/94A patent/AU683494B2/en not_active Ceased
- 1994-09-13 CA CA002171638A patent/CA2171638C/en not_active Expired - Fee Related
- 1994-09-13 EP EP94928057A patent/EP0721342B1/en not_active Expired - Lifetime
- 1994-09-13 DE DE69430130T patent/DE69430130T2/de not_active Expired - Lifetime
- 1994-09-13 PT PT94928057T patent/PT721342E/pt unknown
- 1994-09-13 AT AT94928057T patent/ATE214286T1/de active
-
1997
- 1997-04-08 US US08/835,268 patent/US5807826A/en not_active Expired - Lifetime
- 1997-04-08 US US08/833,391 patent/US6013781A/en not_active Expired - Fee Related
-
1998
- 1998-04-15 US US09/060,692 patent/US5935865A/en not_active Expired - Lifetime
- 1998-04-15 US US09/060,610 patent/US6344544B1/en not_active Expired - Fee Related
-
2002
- 2002-02-04 US US10/067,632 patent/US7153936B2/en not_active Expired - Fee Related
-
2006
- 2006-10-12 US US11/580,373 patent/US20070033669A1/en not_active Abandoned
-
2007
- 2007-06-14 US US11/763,394 patent/US20080312158A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0721342A4 (en) | 1998-07-29 |
DK0721342T3 (da) | 2002-07-15 |
ES2173922T3 (es) | 2002-11-01 |
EP0721342B1 (en) | 2002-03-13 |
US20030166849A1 (en) | 2003-09-04 |
AU7724094A (en) | 1995-04-03 |
US5935865A (en) | 1999-08-10 |
US6013781A (en) | 2000-01-11 |
AU683494B2 (en) | 1997-11-13 |
DE69430130T2 (de) | 2002-08-22 |
JPH09505725A (ja) | 1997-06-10 |
US20070033669A1 (en) | 2007-02-08 |
DE69430130D1 (de) | 2002-04-18 |
WO1995007706A1 (en) | 1995-03-23 |
ATE214286T1 (de) | 2002-03-15 |
JP3544378B2 (ja) | 2004-07-21 |
US5639856A (en) | 1997-06-17 |
CA2171638C (en) | 2001-05-29 |
CA2171638A1 (en) | 1995-03-23 |
US20080312158A1 (en) | 2008-12-18 |
EP0721342A1 (en) | 1996-07-17 |
US6344544B1 (en) | 2002-02-05 |
US5807826A (en) | 1998-09-15 |
US7153936B2 (en) | 2006-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT721342E (pt) | Polipeptidos da familia do gene da semaforina | |
Ji et al. | Bacterial interference caused by autoinducing peptide variants | |
Wower et al. | Labeling the peptidyltransferase center of the Escherichia coli ribosome with photoreactive tRNA (Phe) derivatives containing azidoadenosine at the 3'end of the acceptor arm: a model of the tRNA-ribosome complex. | |
Reeves | Molecular biology of HMGA proteins: hubs of nuclear function | |
Smithgall | SH2 and SH3 domains: potential targets for anti-cancer drug design | |
Gayle et al. | Cloning of a Putative Ligand for the T1/ST2 Receptor (∗) | |
DK0746332T3 (da) | DNA, som koder for en human neuropeptid Y/peptid YY/pankreas-polypeptidreceptor (Y4), samt anvendelse deraf | |
EP0530265A4 (en) | Dna encoding human 5-ht 1d? receptors and uses thereof | |
AU735355C (en) | Novel protein and method for producing the protein | |
GR960300009T1 (pt) | ||
Iler et al. | A single homeodomain binding site restricts spatial expression of Wnt-1 in the developing brain | |
DE69233496D1 (de) | Dna kodierend für den menschlichen 5-ht 1e-rezeptor und seine verwendungen | |
EP0789076A3 (en) | G protein coupled receptor proteins, their production and use | |
JPH10511558A (ja) | 神経薬スクリーニング | |
DE69836220D1 (de) | Den zellzyklus regulierende proteine | |
EP0538395A4 (en) | Nucleic acid sequences encoding a human dopamine d 1? receptor | |
DE69534705D1 (de) | Dickdarm spezifische gene und proteine | |
Lins et al. | OBF1 enhances transcriptional potential of Oct1 | |
ATE304549T1 (de) | Menschliches netrin-1 | |
WO1999027094A3 (en) | HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS | |
No | Biochemical exchange | |
ATE430156T1 (de) | Tumor-oberflächenprotein und sein entsprechender oberflächenrezeptor auf natürlichen killerzellen |